Page last updated: 2024-09-04

carbapenems and oxytocin

carbapenems has been researched along with oxytocin in 3 studies

Compound Research Comparison

Studies
(carbapenems)
Trials
(carbapenems)
Recent Studies (post-2010)
(carbapenems)
Studies
(oxytocin)
Trials
(oxytocin)
Recent Studies (post-2010) (oxytocin)
7,3551475,27721,6111,8315,773

Protein Interaction Comparison

ProteinTaxonomycarbapenems (IC50)oxytocin (IC50)
Oxytocin receptorHomo sapiens (human)0.0027

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Esterly, JS; Malczynski, M; Qi, C; Scheetz, MH1
Karah, N; Samuelsen, Ø; Sundsfjord, A; Towner, K1
Al Johani, SM; Al Salman, J; Al-Abri, S; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Kutbi, AH; Paterson, DL; Sartor, AL; Schlebusch, S; Sidjabat, HE; Walsh, TR; Zowawi, HM1

Reviews

1 review(s) available for carbapenems and oxytocin

ArticleYear
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2012, Volume: 15, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Molecular Epidemiology; Oxytocin

2012

Other Studies

2 other study(ies) available for carbapenems and oxytocin

ArticleYear
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
    Pharmacotherapy, 2010, Volume: 30, Issue:4

    Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Doripenem; Genotype; Hospitals; Humans; Imipenem; Meropenem; Oxytocin; Polymerase Chain Reaction; Thienamycins

2010
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin

2014